LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.91 | 17.25 | 9282 | 5730 | 1.6197 | 1.1185 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.91 | 17.25 | 9424 | 5730 | 1.6445 | 1.1224 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.88 | 17.25 | 47 | 5826 | 0.0081 | 0.1267 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.88 | 17.25 | 9426 | 5826 | 1.6179 | 1.1179 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.88 | 17.25 | 9424 | 5826 | 1.6176 | 1.1179 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.88 | 17.25 | 9597 | 5826 | 1.6473 | 1.1224 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.85 | 17.25 | 49 | 5861 | 0.0084 | 0.1322 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.85 | 17.25 | 9762 | 5861 | 1.6654 | 1.1251 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.85 | 17.25 | 9489 | 5861 | 1.6188 | 1.1179 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.85 | 17.25 | 9874 | 5861 | 1.6845 | 1.1280 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 84.82 | 17.25 | 57 | 5924 | 0.0096 | 0.1524 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 84.82 | 17.25 | 10094 | 5924 | 1.7039 | 1.1306 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 84.82 | 17.25 | 9748 | 5924 | 1.6455 | 1.1218 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 84.82 | 17.25 | 10043 | 5924 | 1.6953 | 1.1293 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 86.79 | 17.25 | 41 | 6008 | 0.0068 | 0.1080 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 86.79 | 17.25 | 10414 | 6008 | 1.7333 | 1.1346 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 86.79 | 17.25 | 9744 | 6008 | 1.6218 | 1.1179 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 86.79 | 17.25 | 10242 | 6008 | 1.7046 | 1.1304 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 88.76 | 17.25 | 46 | 6047 | 0.0076 | 0.1230 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 88.76 | 17.25 | 10773 | 6047 | 1.7813 | 1.1414 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 88.76 | 17.25 | 8127 | 6047 | 1.3438 | 1.0711 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 88.76 | 17.25 | 10502 | 6047 | 1.7365 | 1.1349 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 90.74 | 17.25 | 48 | 6109 | 0.0079 | 0.1284 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 90.74 | 17.25 | 11179 | 6109 | 1.8298 | 1.1479 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 90.74 | 17.25 | 8163 | 6109 | 1.3361 | 1.0696 | MN20160310_N02 | L04 |